Stay updated on NEOPEMBROV Clinical Trial: Ovarian Cancer Tmt
Sign up to get notified when there's something new on the NEOPEMBROV Clinical Trial: Ovarian Cancer Tmt page.

Latest updates to the NEOPEMBROV Clinical Trial: Ovarian Cancer Tmt page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe Publications section now notes that PubMed entries are automatically populated and may not all relate to the study, and the page revision has been updated to version v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe temporary government funding status notice has been removed. The study details, eligibility criteria, and other page content remain unchanged.SummaryDifference0.3%

- Check49 days agoChange DetectedNo additions or deletions were observed; the page content remains unchanged.SummaryDifference0.4%

- Check71 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference2%

- Check78 days agoChange DetectedPage updated to v3.1.0; removed the Ovarian cancer resource and old v3.0.2 reference.SummaryDifference0.2%

- Check92 days agoChange DetectedMajor update: the study now lists 22 locations with Plérin, France added, and it is updated to revision v3.0.2 with an estimated 2025 last-update label; older 2024 data (21 locations, v3.0.1) has been removed.SummaryDifference0.7%

Stay in the know with updates to NEOPEMBROV Clinical Trial: Ovarian Cancer Tmt
Enter your email address, and we'll notify you when there's something new on the NEOPEMBROV Clinical Trial: Ovarian Cancer Tmt page.